[1] Le MH, Yeo YH, Li X, et al.2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis[J]. Clin Gastroenterol Hepatol, 2022, 20(12): 2809-2817.e28. [2] Jiang W, Mao X, Liu Z, et al.Global burden of nonalcoholic fatty liver disease, 1990 to 2019: findings from the global burden of disease study 2019[J]. J Clin Gastroenterol, 2023, 57(6): 631-639. [3] Chalasani N, Younossi Z, Lavine JE, et al.The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases[J]. Hepatology, 2018, 67(1): 328-357. [4] Verrastro O, Panunzi S, Castagneto-Gissey L, et al.Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial[J]. Lancet, 2023, 401(10390): 1786-1797. [5] Perysinakis I, Pappis HC, Margaris E.Current Controversies in Metabolic Surgery for Nonalcoholic Fatty Liver Disease[J]. Obes Surg, 2019, 29(3):1058-1067. [6] Lee Y, Doumouras AG, Yu J, et al. Complete resolution of nonalcoholic fatty liver disease after bariatric surgery: a systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2019, 17(6): 1040-1060. e11. [7] 陈伟, 罗衡桂, 赵象文, 等. 腹腔镜袖状胃切除术对重度肥胖患者非酒精性脂肪肝病及糖脂代谢的短期影响[J]. 中华肥胖与代谢病电子杂志, 2020, 6(03): 153-158. [8] 杨家林, 彭勇. 减重手术治疗非酒精性脂肪性肝病的研究进展[J]. 中国现代普通外科进展, 2021, 24(1): 51-53+57. [9] Li J, Delamarre A, Wong VWS, et al.Diagnosis and assessment of disease severity in patients with nonalcoholic fatty liver disease[J]. United European Gastroenterol J, 2024, 12(2): 219-225. [10] Salman MA, Mikhail HMS, Nafea MA, et al.Impact of laparoscopic sleeve gastrectomy on fibrosis stage in patients with child- A NASH-related cirrhosis[J]. Surg Endosc, 2021, 35: 1269-1277. [11] Liu YW, Wong WS, Wong KH,et al.A prospective 5-year study on the use of transient elastography to monitor the improvement of non-alcoholic fatty liver disease following bariatric surgery[J]. Sci Rep, 2021, 11(1):5416. [12] Nogami A, Yoneda M, Kobayashi T, et al.Assessment of 10‐year changes in liver stiffness using vibration‐controlled transient elastography in non‐alcoholic fatty liver disease[J]. Hepatol Res, 2019, 49(8): 872-880. [13] Lee HW, Wong GLH, Kwok R, et al.Serial transient elastography examinations to monitor patients with type 2 diabetes: a prospective cohort study[J]. Hepatology, 2020, 72(4): 1230-1241. [14] Fakhry TK, Mhaskar R, Schwitalla T, et al.Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis[J]. Surg Obes Relat Dis. 2019, 15(3): 502-511. [15] Gudan A, Kozłowska-Petriczko K, Wunsch E, et al.Small intestinal bacterial overgrowth and non-alcoholic fatty liver disease: what do we know in 2023?[J]. Nutrients, 2023, 15(6): 1323. [16] Sepúlveda M, Alamo M, Astorga C, et al.Histologic and microbiological findings of the defunctionalized loop in sleeve gastrectomy with jejunal bypass[J]. Surg Obes Relat Dis, 2021, 17(1): 131-138. [17] Zhou H, Luo P, Li P, et al.Bariatric Surgery Improves Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis[J]. Obes Surg, 2022, 32(6): 1872-1883. [18] Lin S, Li C, Guan W, et al.Three-Year Outcomes of Sleeve Gastrectomy Plus Jejunojejunal Bypass: a Retrospective Case-Matched Study with Sleeve Gastrectomy and Gastric Bypass in Chinese Patients with BMI ≥35 kg/m2[J]. Obes Surg, 2021, 31(8): 3525-3530. [19] Sepulveda M, Alamo M, Preiss Y, et al.Metabolic surgery comparing sleeve gastrectomy with Jejunal bypass and Roux-en-Y gastric bypass in type 2 diabetic patients after 3 years[J]. Obes Surg, 2018, 28(11): 3466-3473. [20] Zhen Q I, Shenglong LE, Cheng R, et al.Responses of the Serum Lipid Profile to Exercise and Diet Interventions in Nonalcoholic Fatty Liver Disease[J]. Med Sci Sports Exerc, 2024, 56(6): 1036-1045. |